bortezomib,daratumumab,dexamethasone
janssen
['daratumumab']
dr. kastritis from greece presents data on daratumumab monotherapy in high risk (stage 3b) al amyloidosis at #ash22 session 653. clinically meaningful hematologic and cardiac responses 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.